Clinical Trials Logo

Clinical Trial Summary

A retrospective cohort analysis was performed comparing patients that had intra operative antegrade liver reperfusions versus patients that had retrograde liver perfusion.


Clinical Trial Description

A retrospective cohort analysis was performed comparing patients that had intra operative antegrade liver reperfusions versus patients that had retrograde liver perfusion. Antegrade Reperfusion(ATR) group: after completing the caval replacement or piggy-back, for IVC anastomosis, Portal vein (PV) anastomosis was done with a running suture as normal fashion, then it was followed by the removal the clamps, starting by the supra hepatic VC, followed by the PV clamp and finally the infrahepatic VC. It was followed by arterial anastomosis and the biliary anastomosis (duct-to-duct if possible). Retrograde group (RETR): after completing the piggyback the IVC was declamped immediately and retrograde low pressure reperfusion of the graft with low oxygenated venous blood was established. Central venous pressure was intended to be higher than in 8 mmHg to enable appropriate retrograde reperfusion in the transplanted liver. Significant venous backflow via portal vein appears immediately after declamping. Venous bleeding from the liver except portal backflow was stopped immediately after declamping the venous anastomosis, as appropriate. Portal vein anastomosis was performed using running suture. It was followed by arterial anastomosis and the biliary anastomosis (duct-to-duct if possible). The endpoints are patient survival and graft survival at 1, 3,5, 10 years post liver transplantation in both groups. To adjust for a selection bias, we will perform a propensity score analysis. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03846089
Study type Observational
Source London Health Sciences Centre
Contact
Status Withdrawn
Phase
Start date January 1, 2002
Completion date February 28, 2020

See also
  Status Clinical Trial Phase
Completed NCT04789213 - Mortality, Morbidity and Risk Factors of Liver Retransplantation
Completed NCT03858088 - Early Allograft Failure Simplified Estimation (EASE) in Liver Transplantation
Recruiting NCT06225206 - Analysis of Donor-derived Cell Free DNA in Liver Transplant Patients
Active, not recruiting NCT03815864 - Antibodies and Liver Retransplantation
Recruiting NCT05361044 - Liver Graft Viability Assessment During Normothermic Regional Perfusion N/A
Recruiting NCT05866796 - Serum GLYcomics to Predict Graft Loss and Mortality After Liver Transplantation
Active, not recruiting NCT03396016 - Plasmatic Factor V as a Predictor of Graft Dysfunction After Liver Transplantation